by Team Small News | Sep 3, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Eribulin Mesylate Injection, 1mg/2mL (0.5 mg/mL) Single-Dose Vials. The product is bioequivalent and therapeutically equivalent to the reference listed drug, Halaven Injection, 1 mg/2 mL (0.5... by Team Small News | Sep 2, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has made a significant breakthrough in the US market by launching the first complex generic cancer drug, Fulvestrant Injection, 250 mg/5 mL (50 mg/mL). This is a generic version of Faslodex, an injectable medication used to treat hormone...
by Team Small News | Aug 25, 2025 | Glenmark, Pharma, Zydus
The High Court of Sikkim has recently overturned a decision by the GST authorities to deny Zydus Wellness budgetary support of ₹59.44 lakh. The court ruled that the rejection was “untenable in law” and went against established judicial precedent. The GST... by Team Small News | Aug 25, 2025 | Cipla, Glenmark, Lupin, Mankind, Pharma
Several Indian pharmaceutical companies, including Cipla, Glenmark, Lupin, and Mankind Pharma, have demerged their consumer healthcare businesses to focus on growth and expansion. This trend is also being seen globally, with companies like GlaxoSmithKline, Johnson and... by Team Small News | Aug 20, 2025 | Glenmark, Pfizer, Pharma
Glenmark Pharmaceuticals Inc. USA and Pfizer Inc., along with its generic-drug unit Greenstone LLC, have reached a settlement agreement to resolve price-fixing claims brought by direct purchasers of generic drugs. According to the terms of the agreement, Glenmark... by Team Small News | Jul 4, 2025 | Cipla, Glenmark, Lupin, Mankind, Pharma
Lupin, a leading pharmaceutical company, has created a new subsidiary called LupinLife Consumer Healthcare Ltd to house its consumer healthcare business. This move is in line with a growing trend among pharmaceutical companies, both in India and globally, to separate...